Tue, Sep 2, 2014, 10:07 AM EDT - U.S. Markets close in 5 hrs 53 mins

Recent

% | $
Quotes you view appear here for quick access.

Nxstage Medical, Inc. Message Board

  • david_reaves david_reaves Sep 22, 2011 11:38 AM Flag

    Frequent dialysis benefit

    The new retrospective study published in the NEJM should be beneficial to NxStage if the results hold up. The study found that the day after the 2-day weekend for thrice weekly treatment had more cardiac events and more deaths. With the NxStage frequent treatment modality, there's no 2-day weekend. Patients don't suffer the extreme swings in fluid or toxins.

    As a patient I've felt much better with NxStage than I did on conventional dialysis. The frequency of treatment is the key benefit. Of course, the flexibility to manage my own dialysis schedule and the ability to travel with the system are strong positives, too.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Time/duration of treatment more important then frequency for metabolic clearance. More frequent treatments are better to control BP/fluid gain and prevent intradialytic hypotension or myocardial stunning.(you feel better because of less osmotic dysequilibrium) And yes a low K bath is horrible for dialysis patients. The rapidity of lowering can provoke cardiac arrythmias. However, longer term next-stage is just as bad as conventional thrice weekly dialysis. FYI. IT is the same more or less, but convenient. Clinical outcomes are unchanged sadly.

      • 1 Reply to aaktx2
      • "It is the same, more or less..."

        You sound like a clinician with little regard for the patient's quality of life. Your off-hand comment disregards the benefits to the patient to be able to schedule one's own treatment, to travel freely, and to have a somewhat normal life. The fact that I can consume relatively normal amounts of fluid and that I never have to suffer through a weekend with two days between treatments are all more than enough for me to continue with NxStage.

        I will agree that once I can start doing daily slow/nocturnal treatments that I should have better labs and a better long-term outcome. For the home-hemo systems that I know about, though, the additional flexibility and ease-of-use makes NxStage well worth it.

    • good post

 
NXTM
13.19+0.07(+0.52%)10:03 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.